breast cancer - International Biopharmaceutical Industry

Current Edition

Volume 4 Issue 4

Understanding the Role of Regulatory T Cells in Breast Cancer Metastasis

Breast cancer is the most common cancer amongst women accounting for 24 percent of new cancer cases worldwide and 15 percent of cancer deaths in 2018. While survival ...

9 December 2021 Volume 4 Issue 4 breast cancer | cancer

Continue Reading →

news

Lilly drug cleared by FDA for wider use in breast cancer

The new label opens up a significant market opportunity for Lilly, as about 70% of people diagnosed with breast cancer have the hormone receptor positive, HER-2 negat...

15 October 2021 news breast cancer | FDA

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Understanding the Role of Regulatory T Cells in Breast Cancer Metastasis

Lilly drug cleared by FDA for wider use in breast cancer

International Biopharmaceutical Industry